(Q43750588)

26 November 2017

Effect of glucocorticoid excess on the cortisol/cortisone ratio (English)

1 reference

26 November 2017

0 references

Dötsch J

1

1 reference

26 November 2017

Dörr HG

series ordinal

2

1 reference

26 November 2017

Stalla GK

series ordinal

3

1 reference

26 November 2017

Sippell WG

series ordinal

4

1 reference

26 November 2017

1 November 2001

1 reference

26 November 2017

1 reference

26 November 2017

66

1 reference

26 November 2017

11

1 reference

26 November 2017

817-820

1 reference

Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11 beta-hydroxysteroid dehydrogenase

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Type 2 11 beta-hydroxysteroid dehydrogenase in foetal and adult life

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Purification and characterization of the corticosteroid 11 beta-dehydrogenase component of the rat liver 11 beta-hydroxysteroid dehydrogenase complex

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Molecular analysis of 11 beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Clinical case seminar: Hypokalemia in a 52-year-old woman with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Effect of hypercortisolism and ACTH on the metabolism of cortisol

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Simultaneous radioimmunoassay of plasma aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, 11-deoxycortisol, cortisol and cortisone

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Longitudinal study of progestins, mineralocorticoids, and glucocorticoids throughout human pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Evidence for change of 11beta-hydroxysteroid dehydrogenase activity during infancy and childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Human kidney 11 beta-hydroxysteroid dehydrogenase: regulation by adrenocorticotropin?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Diagnosis and nomenclature of the disorders of the terminal portion of the aldosterone biosynthetic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2801%2900117-9

7 January 2021

10.1016/S0039-128X(01)00117-9

Identifiers

DOI

1 reference

26 November 2017

1 reference